Correlation Between Kalvista Pharmaceuticals and Cogent Biosciences
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and Cogent Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and Cogent Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and Cogent Biosciences, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and Cogent Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of Cogent Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and Cogent Biosciences.
Diversification Opportunities for Kalvista Pharmaceuticals and Cogent Biosciences
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kalvista and Cogent is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and Cogent Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cogent Biosciences and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with Cogent Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cogent Biosciences has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and Cogent Biosciences go up and down completely randomly.
Pair Corralation between Kalvista Pharmaceuticals and Cogent Biosciences
Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 0.7 times more return on investment than Cogent Biosciences. However, Kalvista Pharmaceuticals is 1.42 times less risky than Cogent Biosciences. It trades about 0.05 of its potential returns per unit of risk. Cogent Biosciences is currently generating about 0.02 per unit of risk. If you would invest 517.00 in Kalvista Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 498.00 from holding Kalvista Pharmaceuticals or generate 96.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kalvista Pharmaceuticals vs. Cogent Biosciences
Performance |
| Timeline |
| Kalvista Pharmaceuticals |
| Cogent Biosciences |
Kalvista Pharmaceuticals and Cogent Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kalvista Pharmaceuticals and Cogent Biosciences
The main advantage of trading using opposite Kalvista Pharmaceuticals and Cogent Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, Cogent Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cogent Biosciences will offset losses from the drop in Cogent Biosciences' long position.| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
| Cogent Biosciences vs. Larimar Therapeutics | Cogent Biosciences vs. Kura Oncology | Cogent Biosciences vs. Kiniksa Pharmaceuticals | Cogent Biosciences vs. Ideaya Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges |